BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15476323)

  • 1. [The optimal combination of serum tumor markers with bioinformatics in diagnosis of colorectal carcinoma].
    Yu JK; Yang MQ; Jiang TJ; Zheng S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 33(5):407-10. PubMed ID: 15476323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Application of serum tumor markers and support vector machine in the diagnosis of oral squamous cell carcinoma].
    Zhong LP; Zhou XJ; Wei KJ; Yang X; Ma CY; Zhang CP; Zhang ZY
    Shanghai Kou Qiang Yi Xue; 2008 Oct; 17(5):457-60. PubMed ID: 18989582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.
    Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z
    Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.
    Chen XZ; Zhang WH; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    Tumour Biol; 2014 Sep; 35(9):9015-22. PubMed ID: 24906604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW; Jiang B; Han CZ; Jing JX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
    Li F; Li S; Wei L; Liang X; Zhang H; Liu J
    Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of CA 72-4 in colorectal carcinoma. Comparison with CEA and CA 19-9.
    Fernández-Fernández L; Tejero E; Tieso A
    Eur J Surg Oncol; 1995 Aug; 21(4):388-90. PubMed ID: 7664904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis.
    Wen Z; Huang Y; Ling Z; Chen J; Wei X; Su R; Tang Z; Wen Z; Deng Y; Hu Z
    Dis Markers; 2020; 2020():4716793. PubMed ID: 33488842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
    Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
    World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases.
    Yang XQ; Chen C; Peng CW; Liu SP; Li Y
    Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement.
    Chen C; Chen LQ; Yang GL; Li Y
    J Postgrad Med; 2008; 54(3):186-90. PubMed ID: 18626164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M; Visokai V; Lipska L; Topolcan O
    Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in Diagnosis of Colorectal Cancers.
    Singh S; Kumar R; Kumar U; Kumari R
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3133-3136. PubMed ID: 33247667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.